| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.801 | 0.011 | 0.801 | Caspase 9 stimulant | 0.772 0.015 CID_154699985 | ||
| 0.739 | 0.006 | 0.739 | Aldehyde oxidase inhibitor | |||
| 0.731 | 0.005 | 0.831 | Antioxidant | 0.831 0.004 CID_154699985 | CID_154699985 | |
| 0.7 | 0.005 | 0.7 | Caspase 3 stimulant | 0.585 0.011 CID_154699985 | ||
| 0.721 | 0.027 | 0.771 | Apoptosis agonist | 0.771 0.02 CID_154699985 | CID_154699985 | |
| 0.69 | 0.003 | 0.69 | Estrogen receptor beta antagonist | 0.158 0.014 CID_154699985 | ||
| 0.685 | 0.005 | 0.76 | Free radical scavenger | 0.76 0.004 CID_154699985 | CID_154699985 | |
| 0.681 | 0.003 | 0.681 | Estrogen antagonist | 0.232 0.01 CID_154699985 | ||
| 0.683 | 0.005 | 0.775 | Histamine release inhibitor | 0.775 0.004 CID_154699985 | CID_154699985 | |
| 0.661 | 0.003 | 0.811 | Melanin inhibitor | 0.811 0.002 CID_154699985 | CID_154699985 | |
| 0.66 | 0.005 | 0.66 | Amyloid beta aggregation inhibitor | 0.462 0.018 CID_154699985 | ||
| 0.686 | 0.033 | 0.851 | Antiinflammatory | 0.851 0.009 CID_154699985 | CID_154699985 | |
| 0.637 | 0.004 | 0.854 | Monophenol monooxygenase inhibitor | 0.854 0.003 CID_154699985 | CID_154699985 | |
| 0.582 | 0.003 | 0.582 | 5 Hydroxytryptamine uptake stimulant | 0.3 0.045 CID_154699985 | ||
| 0.58 | 0.003 | 0.58 | Estrogen receptor alpha antagonist | 0.08 0.049 CID_154699985 | ||
| 0.577 | 0.002 | 0.577 | Histidine decarboxylase inhibitor | 0.174 0.016 CID_154699985 | ||
| 0.577 | 0.004 | 0.796 | Amylase inhibitor | 0.796 0.002 CID_154699985 | CID_154699985 | |
| 0.621 | 0.049 | 0.829 | Alpha-glucosidase inhibitor | 0.829 0.015 CID_154699985 | CID_154699985 | |
| 0.576 | 0.005 | 0.576 | MAO inhibitor | |||
| 0.597 | 0.031 | 0.838 | Transcription factor NF kappa B inhibitor | 0.838 0.01 CID_154699985 | CID_154699985 | |
| 0.586 | 0.03 | 0.856 | Cyclophilin D inhibitor | 0.856 0.005 CID_154699985 | CID_154699985 | |
| 0.561 | 0.005 | 0.561 | Peroxidase inhibitor | |||
| 0.571 | 0.018 | 0.571 | 5 Hydroxytryptamine release stimulant | 0.389 0.048 CID_154699985 | ||
| 0.551 | 0.014 | 0.551 | GABA C receptor rho-3 antagonist | |||
| 0.548 | 0.012 | 0.625 | Antiamyloidogenic | 0.625 0.007 CID_154699985 | CID_154699985 | |
| 0.535 | 0.003 | 0.535 | Estrogen receptor beta agonist | 0.229 0.004 CID_154699985 | ||
| 0.543 | 0.012 | 0.761 | Hypoglycemic | 0.761 0.004 CID_154699985 | CID_154699985 | |
| 0.531 | 0.002 | 0.531 | Creatine kinase inhibitor | 0.167 0.018 CID_154699985 | ||
| 0.518 | 0.004 | 0.518 | Cystathionine beta-synthase inhibitor | 0.421 0.004 CID_154699985 | ||
| 0.546 | 0.032 | 0.546 | 15-Lipoxygenase inhibitor | |||
| 0.525 | 0.012 | 0.555 | Hypoxia-inducible factor 1 alpha inhibitor | 0.555 0.01 CID_154699985 | CID_154699985 | |
| 0.512 | 0.004 | 0.512 | Estrogen agonist | 0.267 0.006 CID_154699985 | ||
| 0.514 | 0.015 | 0.638 | Nitric oxide antagonist | 0.638 0.008 CID_154699985 | CID_154699985 | |
| 0.517 | 0.018 | 0.618 | Apoptosis antagonist | 0.618 0.008 CID_154699985 | CID_154699985 | |
| 0.511 | 0.017 | 0.511 | Lipoxygenase inhibitor | |||
| 0.496 | 0.005 | 0.496 | MAO B inhibitor | |||
| 0.5 | 0.023 | 0.59 | Spasmolytic | 0.59 0.014 CID_154699985 | CID_154699985 | |
| 0.502 | 0.032 | 0.559 | 5 Hydroxytryptamine release inhibitor | 0.559 0.018 CID_154699985 | CID_154699985 | |
| 0.472 | 0.004 | 0.472 | Aromatase inhibitor | |||
| 0.465 | 0.005 | 0.465 | Acetylcholinesterase inhibitor | 0.182 0.039 CID_154699985 | ||
| 0.452 | 0.004 | 0.8 | Beta glucuronidase inhibitor | 0.8 0.002 CID_154699985 | CID_154699985 | |
| 0.447 | 0.004 | 0.631 | Xanthine oxidase inhibitor | 0.631 0.003 CID_154699985 | CID_154699985 | |
| 0.444 | 0.01 | 0.648 | Hepatoprotectant | 0.648 0.004 CID_154699985 | CID_154699985 | |
| 0.45 | 0.016 | 0.508 | Vasodilator | 0.508 0.011 CID_154699985 | CID_154699985 | |
| 0.419 | 0.005 | 0.421 | Neurotrophic factor enhancer | 0.421 0.005 CID_154699985 | CID_154699985 | |
| 0.46 | 0.053 | 0.702 | Antibacterial | 0.702 0.009 CID_154699985 | CID_154699985 | |
| 0.407 | 0.003 | 0.407 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.106 0.034 CID_154699985 | ||
| 0.41 | 0.009 | 0.41 | Cholinergic | 0.132 0.093 CID_154699985 | ||
| 0.375 | 0.005 | 0.375 | Cholesterol synthesis inhibitor | 0.307 0.011 CID_154699985 | ||
| 0.388 | 0.029 | 0.558 | Tumour necrosis factor alpha release inhibitor | 0.558 0.01 CID_154699985 | CID_154699985 | |
| 0.361 | 0.011 | 0.503 | Protein kinase stimulant | 0.503 0.004 CID_154699985 | CID_154699985 | |
| 0.35 | 0.006 | 0.35 | Breast cancer-resistant protein inhibitor | |||
| 0.349 | 0.006 | 0.712 | Expectorant | 0.712 0.002 CID_154699985 | CID_154699985 | |
| 0.353 | 0.011 | 0.439 | NOS3 expression enhancer | 0.439 0.006 CID_154699985 | CID_154699985 | |
| 0.351 | 0.012 | 0.351 | Protein-tyrosine phosphatase inhibitor | 0.287 0.021 CID_154699985 | ||
| 0.35 | 0.013 | 0.433 | Lipid peroxidase inhibitor | 0.433 0.008 CID_154699985 | CID_154699985 | |
| 0.335 | 0.005 | 0.335 | Carbonic anhydrase III inhibitor | 0.205 0.015 CID_154699985 | ||
| 0.374 | 0.047 | 0.374 | 12-Lipoxygenase inhibitor | |||
| 0.404 | 0.079 | 0.404 | Calcium channel L-type activator | |||
| 0.324 | 0.003 | 0.324 | Estrogen receptor alpha agonist | 0.074 0.013 CID_154699985 | ||
| 0.322 | 0.006 | 0.322 | Carbonic anhydrase XV inhibitor | |||
| 0.322 | 0.008 | 0.322 | Succinate dehydrogenase inhibitor | 0.178 0.07 CID_154699985 | ||
| 0.334 | 0.024 | 0.495 | Platelet adhesion inhibitor | 0.495 0.005 CID_154699985 | CID_154699985 | |
| 0.314 | 0.004 | 0.314 | Mucolytic | 0.307 0.004 CID_154699985 | ||
| 0.329 | 0.022 | 0.329 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.316 | 0.009 | 0.316 | Protein-tyrosine phosphatase 1B inhibitor | 0.268 0.014 CID_154699985 | ||
| 0.317 | 0.016 | 0.387 | Topoisomerase II inhibitor | 0.387 0.011 CID_154699985 | CID_154699985 | |
| 0.307 | 0.007 | 0.319 | Topoisomerase II alpha inhibitor | 0.319 0.006 CID_154699985 | CID_154699985 | |
| 0.332 | 0.039 | 0.332 | Transcription factor STAT3 inhibitor | 0.181 0.162 CID_154699985 | ||
| 0.331 | 0.041 | 0.331 | Transcription factor STAT inhibitor | |||
| 0.312 | 0.025 | 0.312 | Gastrin inhibitor | 0.283 0.046 CID_154699985 | ||
| 0.312 | 0.027 | 0.312 | Dual specificity phosphatase 3 inhibitor | |||
| 0.298 | 0.015 | 0.298 | MAO A inhibitor | |||
| 0.285 | 0.005 | 0.285 | Opioid kappa receptor antagonist | |||
| 0.289 | 0.013 | 0.313 | Alkaline phosphatase inhibitor | 0.313 0.01 CID_154699985 | CID_154699985 | |
| 0.304 | 0.028 | 0.304 | P-glycoprotein inhibitor | 0.25 0.041 CID_154699985 | ||
| 0.313 | 0.046 | 0.313 | Superoxide dismutase inhibitor | |||
| 0.281 | 0.017 | 0.281 | Nitric-oxide synthase stimulant | 0.271 0.021 CID_154699985 | ||
| 0.267 | 0.008 | 0.267 | Carbonic anhydrase VI inhibitor | 0.12 0.029 CID_154699985 | ||
| 0.3 | 0.043 | 0.3 | Psychostimulant | 0.294 0.044 CID_154699985 | ||
| 0.263 | 0.009 | 0.263 | Androgen antagonist | |||
| 0.269 | 0.015 | 0.269 | Aldehyde dehydrogenase inhibitor | 0.221 0.023 CID_154699985 | ||
| 0.326 | 0.074 | 0.732 | Antithrombotic | 0.732 0.006 CID_154699985 | CID_154699985 | |
| 0.319 | 0.073 | 0.485 | Vasodilator, coronary | 0.485 0.018 CID_154699985 | CID_154699985 | |
| 0.276 | 0.033 | 0.276 | Dual specificity phosphatase inhibitor | |||
| 0.248 | 0.005 | 0.248 | Papain-like protease (SARS coronavirus) inhibitor | 0.136 0.05 CID_154699985 | ||
| 0.262 | 0.019 | 0.262 | Cyclooxygenase 1 inhibitor | 0.181 0.043 CID_154699985 | ||
| 0.247 | 0.004 | 0.247 | Ca(v)3.2 blocker | 0.064 0.03 CID_154699985 | ||
| 0.279 | 0.037 | 0.279 | RNA-directed DNA polymerase inhibitor | 0.222 0.072 CID_154699985 | ||
| 0.297 | 0.058 | 0.323 | DNA damaging | 0.323 0.049 CID_154699985 | CID_154699985 | |
| 0.241 | 0.005 | 0.241 | Multidrug resistance-associated protein 1 inhibitor | 0.221 0.007 CID_154699985 | ||
| 0.256 | 0.019 | 0.256 | NADPH oxidase inhibitor | 0.202 0.034 CID_154699985 | ||
| 0.242 | 0.017 | 0.242 | 5-Lipoxygenase inhibitor | |||
| 0.227 | 0.004 | 0.227 | Carbonic anhydrase VII inhibitor | 0.098 0.009 CID_154699985 | ||
| 0.246 | 0.029 | 0.4 | Interferon gamma antagonist | 0.4 0.011 CID_154699985 | CID_154699985 | |
| 0.22 | 0.007 | 0.22 | Electron transport complex I inhibitor | 0.128 0.037 CID_154699985 | ||
| 0.234 | 0.024 | 0.234 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.233 | 0.027 | 0.303 | Interleukin 6 antagonist | 0.303 0.014 CID_154699985 | CID_154699985 | |
| 0.225 | 0.02 | 0.415 | Alkylator | 0.415 0.007 CID_154699985 | CID_154699985 | |
| 0.207 | 0.004 | 0.207 | Ornithine decarboxylase inhibitor | 0.156 0.009 CID_154699985 | ||
| 0.246 | 0.044 | 0.246 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.163 0.119 CID_154699985 | ||
| 0.31 | 0.109 | 0.525 | Immunosuppressant | 0.525 0.027 CID_154699985 | CID_154699985 | |
| 0.205 | 0.007 | 0.205 | Macrophage migration inhibitory factor inhibitor | |||
| 0.217 | 0.019 | 0.217 | Butyrylcholinesterase inhibitor | |||
| 0.254 | 0.058 | 0.254 | Antimitotic | 0.141 0.13 CID_154699985 | ||
| 0.29 | 0.097 | 0.539 | Cholesterol antagonist | 0.539 0.027 CID_154699985 | CID_154699985 | |
| 0.196 | 0.005 | 0.196 | Opioid kappa receptor agonist | 0.064 0.016 CID_154699985 | ||
| 0.212 | 0.023 | 0.212 | GABA C receptor rho-2 antagonist | |||
| 0.277 | 0.089 | 0.277 | Streptokinase A inhibitor | |||
| 0.192 | 0.004 | 0.192 | Ca(v)3.1 blocker | |||
| 0.197 | 0.014 | 0.199 | Carbonic anhydrase XIII inhibitor | 0.199 0.014 CID_154699985 | CID_154699985 | |
| 0.228 | 0.049 | 0.228 | Insulin sensitizer | 0.211 0.063 CID_154699985 | ||
| 0.194 | 0.015 | 0.194 | Opioid antagonist | |||
| 0.221 | 0.045 | 0.221 | Amyloid beta precursor protein antagonist | |||
| 0.18 | 0.005 | 0.18 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.203 | 0.03 | 0.203 | Arachidonic acid antagonist | |||
| 0.178 | 0.005 | 0.178 | Xanthine dehydrogenase inhibitor | 0.09 0.019 CID_154699985 | ||
| 0.208 | 0.038 | 0.208 | Phospholipase A2 inhibitor | 0.175 0.057 CID_154699985 | ||
| 0.184 | 0.016 | 0.266 | Photosensitizer | 0.266 0.005 CID_154699985 | CID_154699985 | |
| 0.207 | 0.039 | 0.207 | Phospholipase C inhibitor | 0.17 0.073 CID_154699985 | ||
| 0.21 | 0.042 | 0.21 | Antipruritic | |||
| 0.277 | 0.109 | 0.277 | Vasodilator, peripheral | 0.232 0.142 CID_154699985 | ||
| 0.178 | 0.011 | 0.178 | DOPA decarboxylase inhibitor | |||
| 0.192 | 0.028 | 0.293 | Topoisomerase I inhibitor | 0.293 0.012 CID_154699985 | CID_154699985 | |
| 0.27 | 0.108 | 0.27 | Sodium/bile acid cotransporter inhibitor | |||
| 0.185 | 0.025 | 0.478 | Cyclooxygenase 3 inhibitor | 0.478 0.003 CID_154699985 | CID_154699985 | |
| 0.184 | 0.024 | 0.229 | Microtubule formation inhibitor | 0.229 0.014 CID_154699985 | CID_154699985 | |
| 0.161 | 0.005 | 0.161 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.151 0.007 CID_154699985 | ||
| 0.164 | 0.008 | 0.164 | Lipase inhibitor | 0.117 0.019 CID_154699985 | ||
| 0.177 | 0.022 | 0.359 | UDP-glucose 4-epimerase inhibitor | 0.359 0.008 CID_154699985 | CID_154699985 | |
| 0.178 | 0.025 | 0.199 | Beta amyloid protein antagonist | 0.199 0.017 CID_154699985 | CID_154699985 | |
| 0.17 | 0.017 | 0.479 | AMP-activated protein kinase stimulant | 0.479 0.003 CID_154699985 | CID_154699985 | |
| 0.167 | 0.016 | 0.167 | Ca2+-transporting ATPase inhibitor | 0.159 0.026 CID_154699985 | ||
| 0.16 | 0.01 | 0.168 | Aldose reductase inhibitor | 0.168 0.009 CID_154699985 | CID_154699985 | |
| 0.169 | 0.021 | 0.169 | GABA C receptor antagonist | |||
| 0.191 | 0.045 | 0.191 | Cyclooxygenase inhibitor | 0.146 0.073 CID_154699985 | ||
| 0.189 | 0.044 | 0.189 | Heat shock protein 90 antagonist | |||
| 0.174 | 0.031 | 0.174 | Adenylate cyclase stimulant | |||
| 0.152 | 0.01 | 0.152 | Alcohol oxidase inhibitor | |||
| 0.178 | 0.036 | 0.182 | DNA polymerase I inhibitor | 0.182 0.034 CID_154699985 | CID_154699985 | |
| 0.178 | 0.038 | 0.178 | CF transmembrane conductance regulator agonist | |||
| 0.159 | 0.02 | 0.205 | Uric acid excretion stimulant | 0.205 0.012 CID_154699985 | CID_154699985 | |
| 0.168 | 0.03 | 0.168 | Chelator | |||
| 0.181 | 0.044 | 0.181 | Tubulin antagonist | |||
| 0.18 | 0.042 | 0.189 | Mannose-6-phosphate isomerase inhibitor | 0.189 0.037 CID_154699985 | CID_154699985 | |
| 0.177 | 0.042 | 0.295 | Alpha-N-acetylglucosaminidase inhibitor | 0.295 0.017 CID_154699985 | CID_154699985 | |
| 0.17 | 0.036 | 0.17 | Proteasome inhibitor | |||
| 0.149 | 0.015 | 0.149 | Analgesic, opioid | |||
| 0.153 | 0.021 | 0.153 | Urease inhibitor | |||
| 0.174 | 0.044 | 0.174 | Bone formation stimulant | 0.144 0.064 CID_154699985 | ||
| 0.159 | 0.029 | 0.291 | Antineoplastic antibiotic | 0.291 0.01 CID_154699985 | CID_154699985 | |
| 0.214 | 0.085 | 0.361 | Hypolipemic | 0.361 0.033 CID_154699985 | CID_154699985 | |
| 0.166 | 0.038 | 0.166 | Interleukin 4 antagonist | 0.15 0.05 CID_154699985 | ||
| 0.147 | 0.022 | 0.186 | Toll-Like receptor 4 antagonist | 0.186 0.009 CID_154699985 | CID_154699985 | |
| 0.13 | 0.009 | 0.13 | Opioid agonist | |||
| 0.144 | 0.024 | 0.144 | GABA C receptor rho-1 antagonist | |||
| 0.142 | 0.021 | 0.142 | Opioid delta receptor antagonist | |||
| 0.193 | 0.078 | 0.193 | Anesthetic general | 0.166 0.098 CID_154699985 | ||
| 0.206 | 0.091 | 0.738 | Angiogenesis stimulant | 0.738 0.004 CID_154699985 | CID_154699985 | |
| 0.124 | 0.009 | 0.144 | Neuraminidase inhibitor | 0.144 0.006 CID_154699985 | CID_154699985 | |
| 0.139 | 0.025 | 0.139 | Anabolic | |||
| 0.14 | 0.027 | 0.14 | Prolactin inhibitor | |||
| 0.174 | 0.062 | 0.174 | Death-associated protein kinase 2 inhibitor | |||
| 0.23 | 0.117 | 0.23 | Insulysin inhibitor | |||
| 0.207 | 0.096 | 0.395 | Platelet antagonist | 0.395 0.028 CID_154699985 | CID_154699985 | |
| 0.164 | 0.053 | 0.341 | Cell wall synthesis inhibitor | 0.341 0.008 CID_154699985 | CID_154699985 | |
| 0.121 | 0.012 | 0.121 | Protein kinase C eta inhibitor | 0.064 0.032 CID_154699985 | ||
| 0.113 | 0.005 | 0.113 | Glutamate (mGluR7) antagonist | |||
| 0.13 | 0.022 | 0.13 | Opioid mu receptor antagonist | |||
| 0.124 | 0.018 | 0.124 | HIV-1 integrase (3'-Processing) inhibitor | 0.08 0.034 CID_154699985 | ||
| 0.15 | 0.046 | 0.155 | Heat shock protein 70 antagonist | 0.155 0.036 CID_154699985 | CID_154699985 | |
| 0.111 | 0.008 | 0.111 | Fatty acid synthase inhibitor | 0.054 0.044 CID_154699985 | ||
| 0.185 | 0.083 | 0.402 | Non-steroidal antiinflammatory agent | 0.402 0.013 CID_154699985 | CID_154699985 | |
| 0.129 | 0.027 | 0.129 | Protein kinase C zeta inhibitor | |||
| 0.155 | 0.053 | 0.155 | MAP kinase kinase 4 inhibitor | |||
| 0.116 | 0.016 | 0.116 | Leukotriene antagonist | 0.103 0.02 CID_154699985 | ||
| 0.105 | 0.005 | 0.105 | Sodium/calcium exchanger inhibitor | 0.049 0.037 CID_154699985 | ||
| 0.119 | 0.021 | 0.119 | Glutamate decarboxylase inhibitor | |||
| 0.112 | 0.014 | 0.112 | Carbonic anhydrase VB inhibitor | |||
| 0.15 | 0.053 | 0.15 | Cyclooxygenase 2 inhibitor | 0.117 0.083 CID_154699985 | ||
| 0.21 | 0.114 | 0.489 | Immunostimulant | 0.489 0.03 CID_154699985 | CID_154699985 | |
| 0.099 | 0.004 | 0.099 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.185 | 0.093 | 0.185 | Interleukin antagonist | |||
| 0.129 | 0.04 | 0.129 | Bronchodilator | |||
| 0.094 | 0.005 | 0.094 | Retinoid X alpha receptor agonist | |||
| 0.243 | 0.155 | 0.243 | Calcium channel activator | |||
| 0.121 | 0.034 | 0.121 | Alcohol dehydrogenase inhibitor | 0.104 0.048 CID_154699985 | ||
| 0.111 | 0.025 | 0.111 | Keratolytic | |||
| 0.154 | 0.071 | 0.323 | Insulin secretagoues | 0.323 0.01 CID_154699985 | CID_154699985 | |
| 0.107 | 0.025 | 0.107 | Carbonic anhydrase V inhibitor | |||
| 0.202 | 0.12 | 0.334 | DNA synthesis inhibitor | 0.334 0.034 CID_154699985 | CID_154699985 | |
| 0.105 | 0.023 | 0.105 | Carbonic anhydrase VA inhibitor | |||
| 0.096 | 0.014 | 0.096 | Opioid mu receptor agonist | |||
| 0.113 | 0.032 | 0.192 | NADH dehydrogenase inhibitor | 0.192 0.011 CID_154699985 | CID_154699985 | |
| 0.09 | 0.01 | 0.09 | Transcription factor RelA inhibitor | |||
| 0.14 | 0.06 | 0.14 | Toll-Like receptor 2 antagonist | |||
| 0.112 | 0.034 | 0.157 | Phosphodiesterase 6D inhibitor | 0.157 0.008 CID_154699985 | CID_154699985 | |
| 0.087 | 0.009 | 0.125 | Glucose-6-phosphate translocase inhibitor | 0.125 0.004 CID_154699985 | CID_154699985 | |
| 0.184 | 0.107 | 0.319 | Cyclic AMP phosphodiesterase inhibitor | 0.319 0.035 CID_154699985 | CID_154699985 | |
| 0.165 | 0.09 | 0.275 | DNA methyltransferase I inhibitor | 0.275 0.036 CID_154699985 | CID_154699985 | |
| 0.103 | 0.029 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.123 0.015 CID_154699985 | CID_154699985 | |
| 0.097 | 0.023 | 0.097 | Glucagon-like peptide 1 agonist | |||
| 0.123 | 0.05 | 0.123 | Protein kinase C gamma inhibitor | |||
| 0.078 | 0.006 | 0.078 | Dopamine D5 agonist | |||
| 0.121 | 0.049 | 0.121 | GABA C receptor agonist | |||
| 0.11 | 0.039 | 0.13 | Interleukin 12 antagonist | 0.13 0.021 CID_154699985 | CID_154699985 | |
| 0.1 | 0.029 | 0.1 | D-Ala-D-Ala ligase inhibitor | |||
| 0.114 | 0.043 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.091 | 0.022 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.1 | 0.032 | 0.181 | Phosphofructokinase-1 inhibitor | 0.181 0.013 CID_154699985 | CID_154699985 | |
| 0.093 | 0.027 | 0.093 | Dopamine D1 antagonist | |||
| 0.112 | 0.047 | 0.112 | Protein kinase C mu inhibitor | |||
| 0.083 | 0.019 | 0.083 | Alpha tubulin antagonist | |||
| 0.095 | 0.032 | 0.095 | Estrogen-related receptor beta agonist | |||
| 0.079 | 0.017 | 0.079 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.115 | 0.053 | 0.252 | Mediator release inhibitor | 0.252 0.009 CID_154699985 | CID_154699985 | |
| 0.105 | 0.043 | 0.201 | Triose-phosphate isomerase inhibitor | 0.201 0.011 CID_154699985 | CID_154699985 | |
| 0.087 | 0.028 | 0.087 | HIV-1 integrase (Strand Transfer) inhibitor | 0.06 0.042 CID_154699985 | ||
| 0.149 | 0.09 | 0.149 | Mcl-1 antagonist | |||
| 0.245 | 0.187 | 0.245 | Analgesic | |||
| 0.082 | 0.024 | 0.132 | Neuraminidase (influenza) inhibitor | 0.132 0.01 CID_154699985 | CID_154699985 | |
| 0.068 | 0.011 | 0.068 | Retinoid X receptor agonist | |||
| 0.094 | 0.039 | 0.094 | CYP2A6 inhibitor | |||
| 0.084 | 0.032 | 0.084 | Secretase beta inhibitor | |||
| 0.068 | 0.016 | 0.068 | Leukotriene C antagonist | |||
| 0.085 | 0.034 | 0.085 | HIV-1 integrase inhibitor | |||
| 0.151 | 0.1 | 0.151 | Tumour necrosis factor antagonist | |||
| 0.055 | 0.005 | 0.055 | Estrogen-related receptor beta antagonist | |||
| 0.08 | 0.03 | 0.08 | Protein kinase C beta inhibitor | |||
| 0.121 | 0.071 | 0.215 | DNA repair enzyme inhibitor | 0.215 0.007 CID_154699985 | CID_154699985 | |
| 0.053 | 0.006 | 0.135 | Sodium/glucose cotransporter 2 inhibitor | 0.135 0.002 CID_154699985 | CID_154699985 | |
| 0.089 | 0.044 | 0.133 | Glycine receptor antagonist | 0.133 0.012 CID_154699985 | CID_154699985 | |
| 0.051 | 0.008 | 0.051 | Tubulin agonist | 0.039 0.016 CID_154699985 | ||
| 0.066 | 0.022 | 0.096 | Leukotriene B4 antagonist | 0.096 0.011 CID_154699985 | CID_154699985 | |
| 0.073 | 0.03 | 0.073 | MDM2 inhibitor | |||
| 0.074 | 0.032 | 0.074 | Glutamate (mGluR6) antagonist | |||
| 0.104 | 0.061 | 0.104 | Gastric antisecretory | |||
| 0.057 | 0.015 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 CID_154699985 | CID_154699985 | |
| 0.087 | 0.046 | 0.087 | Thioredoxin reductase inhibitor | |||
| 0.061 | 0.02 | 0.061 | Squalene epoxidase inhibitor | |||
| 0.079 | 0.038 | 0.079 | Dopamine agonist | |||
| 0.139 | 0.099 | 0.139 | Heat shock protein 90 alpha antagonist | |||
| 0.079 | 0.039 | 0.079 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.082 | 0.043 | 0.082 | Telomerase inhibitor | |||
| 0.044 | 0.006 | 0.148 | Sodium/glucose cotransporter inhibitor | 0.148 0.002 CID_154699985 | CID_154699985 | |
| 0.083 | 0.045 | 0.083 | Porphobilinogen synthase inhibitor | |||
| 0.13 | 0.093 | 0.13 | MAP3K9 inhibitor | |||
| 0.175 | 0.139 | 0.175 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.052 | 0.017 | 0.052 | Progesterone antagonist | |||
| 0.151 | 0.116 | 0.267 | DNA methylase inhibitor | 0.267 0.04 CID_154699985 | CID_154699985 | |
| 0.087 | 0.053 | 0.087 | mTOR complex 2 inhibitor | |||
| 0.15 | 0.115 | 0.15 | Pyruvate kinase inhibitor | |||
| 0.088 | 0.056 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.046 | 0.014 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.103 | 0.071 | 0.182 | DNA intercalator | 0.182 0.031 CID_154699985 | CID_154699985 | |
| 0.048 | 0.016 | 0.088 | Arginase inhibitor | 0.088 0.005 CID_154699985 | CID_154699985 | |
| 0.056 | 0.025 | 0.056 | Topoisomerase II beta inhibitor | 0.045 0.043 CID_154699985 | ||
| 0.092 | 0.063 | 0.129 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.129 0.035 CID_154699985 | CID_154699985 | |
| 0.075 | 0.046 | 0.075 | Glycine receptor agonist | |||
| 0.037 | 0.009 | 0.037 | Estrone sulfatase inhibitor | |||
| 0.232 | 0.203 | 0.232 | DNA directed DNA polymerase inhibitor | |||
| 0.06 | 0.032 | 0.06 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.044 | 0.017 | 0.044 | Leukotriene C4 antagonist | |||
| 0.066 | 0.041 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.054 | 0.028 | 0.054 | CD45 antagonist | |||
| 0.05 | 0.026 | 0.05 | Adenylate cyclase 1 inhibitor | |||
| 0.051 | 0.027 | 0.06 | Microtubule stabilization | 0.06 0.015 CID_154699985 | CID_154699985 | |
| 0.106 | 0.082 | 0.106 | Caspase 3 inhibitor | |||
| 0.037 | 0.015 | 0.037 | ATP citrate lysase inhibitor | |||
| 0.041 | 0.02 | 0.041 | Vanilloid 3 antagonist | |||
| 0.05 | 0.029 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.069 0.013 CID_154699985 | CID_154699985 | |
| 0.05 | 0.029 | 0.05 | Cholesterol esterase inhibitor | |||
| 0.04 | 0.019 | 0.04 | Opioid delta receptor agonist | |||
| 0.037 | 0.017 | 0.037 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.029 | 0.009 | 0.035 | Dopamine D1 agonist | 0.035 0.007 CID_154699985 | CID_154699985 | |
| 0.054 | 0.036 | 0.121 | Carbonic anhydrase XII inhibitor | 0.121 0.016 CID_154699985 | CID_154699985 | |
| 0.089 | 0.073 | 0.089 | Sphingomyelinase inhibitor | |||
| 0.052 | 0.036 | 0.052 | Aconitate hydratase inhibitor | |||
| 0.035 | 0.021 | 0.035 | Glucocorticoid antagonist | |||
| 0.043 | 0.03 | 0.043 | Carbonic anhydrase IV inhibitor | |||
| 0.058 | 0.046 | 0.058 | Purinergic P2X1 antagonist | |||
| 0.053 | 0.042 | 0.053 | Dihydroorotate oxidase inhibitor | |||
| 0.02 | 0.01 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.003 CID_154699985 | CID_154699985 | |
| 0.166 | 0.155 | 0.383 | Peptidyltransferase inhibitor | 0.383 0.008 CID_154699985 | CID_154699985 | |
| 0.037 | 0.026 | 0.037 | 5-Alpha-reductase inhibitor | |||
| 0.062 | 0.053 | 0.062 | Leukotriene synthesis inhibitor | |||
| 0.018 | 0.009 | 0.018 | NMDA receptor phencyclidine site antagonist | |||
| 0.031 | 0.022 | 0.031 | Cholesterol ester transfer protein antagonist | |||
| 0.056 | 0.048 | 0.056 | Heat shock protein 90 beta antagonist | |||
| 0.098 | 0.091 | 0.098 | TRPA1 agonist | |||
| 0.091 | 0.084 | 0.091 | Adenylate kinase inhibitor | |||
| 0.067 | 0.059 | 0.111 | Histone deacetylase stimulant | 0.111 0.022 CID_154699985 | CID_154699985 | |
| 0.067 | 0.059 | 0.111 | Histone deacetylase SIRT1 stimulant | 0.111 0.022 CID_154699985 | CID_154699985 | |
| 0.219 | 0.211 | 0.219 | DNA polymerase beta inhibitor | |||
| 0.199 | 0.192 | 0.412 | Interleukin 2 agonist | 0.412 0.024 CID_154699985 | CID_154699985 | |
| 0.044 | 0.037 | 0.044 | Potassium channel Kv1.3 blocker | |||
| 0.08 | 0.073 | 0.083 | Interleukin 5 antagonist | 0.083 0.067 CID_154699985 | CID_154699985 | |
| 0.055 | 0.048 | 0.055 | Androgen agonist | |||
| 0.062 | 0.056 | 0.062 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.055 | 0.049 | 0.07 | Lipocortins synthesis agonist | 0.07 0.022 CID_154699985 | CID_154699985 | |
| 0.01 | 0.006 | 0.01 | Progesterone receptor A antagonist | |||
| 0.039 | 0.035 | 0.039 | Leukocyte elastase inhibitor | |||
| 0.077 | 0.073 | 0.077 | Myeloperoxidase inhibitor | |||
| 0.066 | 0.062 | 0.066 | Glutamate dehydrogenase inhibitor | |||
| 0.03 | 0.027 | 0.03 | Catechol O-methyltransferase inhibitor | |||
| 0.026 | 0.022 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.021 | 0.018 | 0.021 | Dopamine autoreceptor agonist | |||
| 0.068 | 0.065 | 0.068 | GABA aminotransferase inhibitor | |||
| 0.033 | 0.03 | 0.084 | Antibiotic Aminoglycoside-like | 0.084 0.004 CID_154699985 | CID_154699985 | |
| 0.134 | 0.132 | 0.247 | ATPase inhibitor | 0.247 0.014 CID_154699985 | CID_154699985 | |
| 0.082 | 0.081 | 0.082 | ABCA1 expression enhancer | |||
| 0.039 | 0.038 | 0.039 | GABA B receptor antagonist | |||
| 0.02 | 0.023 | 0.07 | Protein 30S ribosomal subunit inhibitor | 0.07 0.005 CID_154699985 | CID_154699985 | |
| 0.014 | 0.02 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_154699985 | CID_154699985 | |
| 0.038 | 0.051 | 0.058 | Carbonic anhydrase XIV inhibitor | 0.058 0.026 CID_154699985 | CID_154699985 | |
| 0.043 | 0.06 | 0.086 | Alpha-mannosidase inhibitor | 0.086 0.009 CID_154699985 | CID_154699985 | |
| 0.076 | 0.094 | 0.121 | Thioredoxin inhibitor | 0.121 0.03 CID_154699985 | CID_154699985 | |
| 0.019 | 0.04 | 0.032 | Vanilloid 2 agonist | 0.032 0.008 CID_154699985 | CID_154699985 | |
| 0.062 | 0.091 | 0.085 | Interferon agonist | 0.085 0.045 CID_154699985 | CID_154699985 | |
| 0.03 | 0.064 | 0.081 | Mannosidase inhibitor | 0.081 0.009 CID_154699985 | CID_154699985 | |
| 0.133 | 0.182 | 0.278 | Interleukin agonist | 0.278 0.06 CID_154699985 | CID_154699985 | |
| 0.093 | 0.143 | 0.327 | Thrombolytic | 0.327 0.02 CID_154699985 | CID_154699985 | |
| 0.041 | 0.099 | 0.057 | Transcription factor AP-1 inhibitor | 0.057 0.052 CID_154699985 | CID_154699985 | |
| 0.002 | 0.067 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_154699985 | CID_154699985 | |
| 0.101 | 0.166 | 0.374 | Hemostatic | 0.374 0.009 CID_154699985 | CID_154699985 | |
| 0.096 | 0.166 | 0.203 | Hexokinase inhibitor | 0.203 0.033 CID_154699985 | CID_154699985 | |
| 0.036 | 0.106 | 0.075 | Nitric oxide donor | 0.075 0.027 CID_154699985 | CID_154699985 | |
| 0.031 | 0.118 | 0.046 | Cytokine production stimulant | 0.046 0.042 CID_154699985 | CID_154699985 | |
| 0.085 | 0.177 | 0.19 | Diuretic | 0.19 0.048 CID_154699985 | CID_154699985 | |
| 0.108 | 0.201 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.028 CID_154699985 | CID_154699985 | |
| 0.023 | 0.117 | 0.105 | Protein 50S ribosomal subunit inhibitor | 0.105 0.012 CID_154699985 | CID_154699985 | |
| 0.031 | 0.129 | 0.096 | Heparanase inhibitor | 0.096 0.004 CID_154699985 | CID_154699985 | |
| 0.015 | 0.135 | 0.044 | Phosphorylase inhibitor | 0.044 0.034 CID_154699985 | CID_154699985 | |
| 0.033 | 0.154 | 0.068 | DNA gyrase inhibitor | 0.068 0.038 CID_154699985 | CID_154699985 | |
| 0.006 | 0.133 | 0.032 | Squalene synthetase inhibitor | 0.032 0.022 CID_154699985 | CID_154699985 | |
| 0.036 | 0.179 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.031 CID_154699985 | CID_154699985 | |
| 0.031 | 0.177 | 0.048 | Factor III inhibitor | 0.048 0.042 CID_154699985 | CID_154699985 | |
| 0.059 | 0.219 | 0.091 | T cell inhibitor | 0.091 0.037 CID_154699985 | CID_154699985 | |
| 0.04 | 0.223 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.115 0.023 CID_154699985 | CID_154699985 | |
| 0.112 | 0.306 | 0.271 | Angiogenesis inhibitor | 0.271 0.109 CID_154699985 | CID_154699985 | |
| 0.056 | 0.261 | 0.269 | Cell adhesion inhibitor | 0.269 0.013 CID_154699985 | CID_154699985 | |
| 0.106 | 0.354 | 0.249 | Antiobesity | 0.249 0.157 CID_154699985 | CID_154699985 | |
| 0.045 | 0.295 | 0.127 | Transcription factor NF kappa B stimulant | 0.127 0.022 CID_154699985 | CID_154699985 | |
| 0.013 | 0.281 | 0.346 | Selectin antagonist | 0.346 0.004 CID_154699985 | CID_154699985 | |
| 0.011 | 0.456 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 CID_154699985 | CID_154699985 | |
| 0.017 | 0.579 | 0.195 | Anticoagulant | 0.195 0.055 CID_154699985 | CID_154699985 | |
| 0.04 | 0.645 | 0.355 | Immunomodulator | 0.355 0.058 CID_154699985 | CID_154699985 | |
| 0.012 | 0.734 | 0.054 | Factor IXa inhibitor | 0.054 0.032 CID_154699985 | CID_154699985 | |
| 0.007 | 0.742 | 0.082 | Cell adhesion molecule inhibitor | 0.082 0.05 CID_154699985 | CID_154699985 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |